US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.148
  • +0.005+3.72%
Close Nov 27 16:00 ET
5.88MMarket Cap-134P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viracta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Viracta Therapeutics Earnings Reports

  • Viracta Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:36 ET

  • Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 13 07:33 ET

  • Viracta Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:12 ET

  • Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 14 07:19 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data